Top Research Publications: August 2022

Sep 21, 2022

Epidemiology

Munger MA, Nelson SD, Teng CC, Cheung AK, Sauer BC. Reduced risk of NSAID-Induced adverse events with concomitant use of misoprostol (MICRO study). Pharmacotherapy. 2022 Jul;42(7):540-548. doi: 10.1002/phar.2708. Epub 2022 Jun 16. PMID: 35661392.
Cannon-Albright LA, Romesser J, Teerlink CC, Thomas A, Meyer LJ. Evidence for excess familial clustering of Post Traumatic Stress Disorder in the US Veterans Genealogy resource. J Psychiatr Res. 2022 Jun;150:332-337. doi: 10.1016/j.jpsychires.2021.12.018. Epub 2021 Dec 11. PMID: 34953562.
Jones AL, Rafferty J, Cochran SD, Abelson J, Hanna MR, Mays VM. Prevalence, Severity and Burden of Post-Traumatic Stress Disorder in Black Men and Women Across the Adult Life span. J Aging Health. 2022 Jun;34(3):401-412. doi: 10.1177/08982643221086071. Epub 2022 May 5. PMID: 35510479; PMCID: PMC9175561.

Gastroenterology, Hepatology & Nutrition

Ma C, Bredenoord AJ, Dellon ES, Alexander JA, Biedermann L, Hogan M, Guizzetti L, Zou G, Katzka DA, Chehade M, Falk GW, Furuta GT, Gupta SK, Kagalwalla AF, Schoepfer AM, Miehlke S, Moawad FJ, Peterson K, Gonsalves NP, Straumann A, Wechsler JB, Rémillard J, Shackelton LM, Almonte HS, Feagan BG, Jairath V, Hirano I.  Reliability and responsiveness of endoscopic disease activity assessment in eosinophilic esophagitis. Gastrointest Endosc. 2022 Jun;95(6):1126-1137.e2. doi: 10.1016/j.gie.2022.01.014. Epub 2022 Feb 1. PMID: 35120883
Dellon ES, Khoury P, Muir AB, Liacouras CA, Safroneeva E, Atkins D, Collins MH, Gonsalves N, Falk GW, Spergel JM, Hirano I, Chehade M, Schoepfer AM, Menard-Katcher C, Katzka DA, Bonis PA, Bredenoord AJ, Geng B, Jensen ET, Pesek RD, Feuerstadt P, Gupta SK, Lucendo AJ, Genta RM, Hiremath G, McGowan EC, Moawad FJ, Peterson KA, Rothenberg ME, Straumann A, Furuta GT, Aceves SS. A Clinical Severity Index for Eosinophilic Esophagitis: Development, Consensus, and Future Directions. Gastroenterology. 2022 May 16:S0016-5085(22)00287-6. doi: 10.1053/j.gastro.2022.03.025. Online ahead of print. PMID: 35606197
Uchida A, Ro G, Garber J, Peterson K, Round J. Models and Tools for Investigating Eosinophilic Esophagitis at the Bench. Frontiers. Online ahead of print

General Internal Medicine

Incze MA, Kelley AT, Johnson K. Reexamining Medicaid Patient Review and Restriction Programs Amid the Evolving Opioid Epidemic. JAMA Intern Med. 2022 Jun 6. doi: 10.1001/jamainternmed.2022.1952. Epub ahead of print. PMID: 35666512.
Burke LE, Sereika SM, Bizhanova Z, Parmanto B, Kariuki J, Cheng J, Beatrice B, Cedillo M, Pulantara IW, Wang Y, Loar I, Conroy MB. The Effect of Tailored, Daily, Smartphone Feedback to Lifestyle Self-Monitoring on Weight Loss at 12 Months: the SMARTER Randomized Clinical Trial. J Med Internet Res. 2022 Jul 5;24(7):e38243. doi: 10.2196/38243. PMID: 35787516; PMCID: PMC9297147.
Balch H, Gradick C, Kukhareva PV, Wanner N. Association of Mobile Workstations and Rounding-in-Flow with Resident Efficiency: A Controlled Study at an Academic Internal Medicine Department. J Gen Intern Med. 2022 May 5. doi: 10.1007/s11606-022-07636-9. Epub ahead of print. PMID: 35513750.

Hematology & Hematologic Malignancies

May 2022

Abou-Ismail MY, Moser KA, Smock KJ, Lim MY. Vaccine-induced thrombotic thrombocytopenia following Ad26.COV2.S vaccine in a man presenting as acute venous thromboembolism. Am J Hematol. 2021 Sep 1;96(9):E346-E349. doi: 10.1002/ajh.26265. Epub 2021 Jun 17. PMID: 34096082; PMCID: PMC8212083.
Stoller ML, Basak I, Denorme F, Rowley JW, Alsobrooks J, Parsawar K, Nieman MT, Yost CC, Hamilton JR, Bray PF, Campbell RA. Neutrophil Cathepsin G Proteolysis of Protease Activated Receptor 4 Generates a Novel, Functional Tethered Ligand. Blood Adv, 2021 Dec 9:bloodadvances.2021006133. doi: 10.1182/bloodadvances.2021006133. Online ahead of print. PMID: 34883511
Marcero JR, Cox JE, Bergonia HA, Medlock AE, Phillips JD, Dailey HA. The immunometabolite itaconate inhibits heme synthesis and remodels cellular metabolism in erythroid precursors. Blood Adv. 2021 Dec 14;5(23):4831-4841. doi: 10.1182/bloodadvances.2021004750. PMID: 34492704.
Beaudin AE. Takes one to B1a: Dismantling the origin of mantle cell lymphoma. J Exp Med. 2021 Oct 4;218(10):e20211482. doi: 10.1084/jem.20211482. Epub 2021 Sep 16. PMID: 34529750; PMCID: PMC8449273.

July 2022

Christian JL, Hill CS. Transforming growth factor-β family biology: From basic mechanisms to roles in development and disease. Dev Dyn. 2022 Jan;251(1):6-9. doi: 10.1002/dvdy.445. PMID: 34978121.
Farrell CP, Nicolas G, Desnick RJ, Parker CJ, Lamoril J, Gouya L, Karim Z, Tchernitchko D, Chan B, Puy H, Phillips JD. ABCB6 polymorphisms are not overly represented in patients with porphyria. Blood Adv. 2022 Feb 8;6(3):760-766. doi: 10.1182/bloodadvances.2021005484. PMID: 34724702.
Reeves BN, Kim SJ, Song J, Wilson KJ, Henderson MW, Key NS, Pawlinski R, Prchal JT. Tissue factor activity is increased in neutrophils from JAK2 V617F-mutated essential thrombocythemia and polycythemia vera patients. Am J Hematol. 2022 Feb 1;97(2):E37-E40. doi: 10.1002/ajh.26402. Epub 2021 Nov 14. PMID: 34748652.
Wesson W, Galate VL, Sborov DW, McClune B, Goodman AM, Gyawali B, Prasad V, Abbasi S, Mohyuddin GR. Characteristics of clinical trials for haematological malignancies from 2015 to 2020: A systematic review. Eur J Cancer. 2022 May;167:152-160. doi: 10.1016/j.ejca.2021.12.037. Epub 2022 Feb 27. PMID: 35236569.

Oncology

Agarwal N, McGregor B, Maughan BL, Dorff TB, Kelly W, Fang B, McKay RR, Singh P, Pagliaro L, Dreicer R, Srinivas S, Loriot Y, Vaishampayan U, Goel S, Curran D, Panneerselvam A, Schwickart M, Choueiri TK, Pal S. Cabozantinib in combination with atezolizumab in patients with metastatic castration-resistant prostate cancer: results from an expansion cohort of a multicentre, open-label, phase 1b trial (COSMIC-021). Lancet Oncol. 2022 Jul;23(7):899-909. doi: 10.1016/S1470-2045(22)00278-9. Epub 2022 Jun 9. PMID: 35690072.
Dang C, Ewer MS, Delaloge S, Ferrero JM, Colomer R, de la Cruz-Merino L, Werner TL, Dadswell K, Verrill M, Eiger D, Sarkar S, de Haas SL, Restuccia E, Swain SM. BERENICE Final Analysis: Cardiac Safety Study of Neoadjuvant Pertuzumab, Trastuzumab, and Chemotherapy Followed by Adjuvant Pertuzumab and Trastuzumab in HER2-Positive Early Breast Cancer. Cancers (Basel). 2022 May 24;14(11):2596. doi: 10.3390/cancers14112596. PMID: 35681574.
de la Fuente MI, Colman H, Rosenthal M, Van Tine BA, Levacic D, Walbert T, Gan HK, Vieito M, Milhem MM, Lipford K, Forsyth S, Guichard SM, Mikhailov Y, Sedkov A, Brevard J, Kelly PF, Mohamed H, Monga V. Olutasidenib (FT-2102) in patients with relapsed or refractory IDH1-mutant glioma: a multicenter, open-label, phase 1b/2 trial. Neuro Oncol. 2022 May 25:noac139. doi: 10.1093/neuonc/noac139. Online ahead of print.PMID: 35639513.